Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShares OutstandingShares Outstanding
Ratios

Silence Therapeutics (SLN) Leases (2023 - 2025)

Silence Therapeutics' Leases history spans 3 years, with the latest figure at $167000.0 for Q4 2025.

  • On a quarterly basis, Leases rose 6.37% to $167000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $167000.0, a 6.37% increase, with the full-year FY2025 number at $167000.0, up 6.37% from a year prior.
  • Leases hit $167000.0 in Q4 2025 for Silence Therapeutics, down from $192000.0 in the prior quarter.
  • Over the last five years, Leases for SLN hit a ceiling of $370000.0 in Q4 2023 and a floor of $58000.0 in Q2 2025.
  • Historically, Leases has averaged $175166.7 across 3 years, with a median of $162000.0 in 2024.
  • Biggest five-year swings in Leases: tumbled 57.57% in 2024 and later grew 6.37% in 2025.
  • Tracing SLN's Leases over 3 years: stood at $370000.0 in 2023, then tumbled by 57.57% to $157000.0 in 2024, then grew by 6.37% to $167000.0 in 2025.
  • Business Quant data shows Leases for SLN at $167000.0 in Q4 2025, $192000.0 in Q3 2025, and $58000.0 in Q2 2025.